Inventor · disambiguated record
Mark Kontny
Also filed as: KONTNY MARK · KONTNY MARK J · KONTNY MARK JAMES
6 granted patents·7 pending applications·319 citations·filing 1995–2005
87Inventor score
Top patents by PatentIndex Score
13 records- 0191US5676930AStabilized medicinal aerosol solution formulationsBOEHRINGER INGELHEIM PHARMA·Filed 1995·Granted Oct 14, 1997·118 cites·16 claims
- 0289US5955058AStabilized medicinal aerosol solution formulations containing ipratropium bromideBOEHRINGER INGELHEIM PHARMA·Filed 1997·Granted Sep 21, 1999·89 cites·28 claims
- 0387US6045778AStabilized medicinal aerosol solution formulationsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Apr 4, 2000·69 cites·14 claims
- 0486US6890920B2Quaternary ammonium compoundsUPJOHN CO·Filed 2002·Granted May 10, 2005·29 cites·29 claims
- 0580US7172769B2Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectPHARMACIA CORP·Filed 2000·Granted Feb 6, 2007·13 cites·17 claims
- 0671US7439397B2Phenol derivativePFIZER·Filed 2005·Granted Oct 21, 2008·1 cites·2 claims
- 0748US2002142045A1Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectFiled 2002·Application pending·0 cites
- 0846US2003064098A1Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectFiled 2001·Application pending·0 cites
- 0942US2002119193A1Oral fast-melt formulation of a cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1042US2005043296A1Compositions and methods for treating sexual dysfunctionFiled 2003·Application pending·0 cites
- 1137US2002071857A1Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1237US2002049233A1Oral fast-melt dosage form of a cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1329US2002013357A1Valdecoxib compositionsFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Kontny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →